News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Next-generation “epigenetic” cancer pill shown to be safe
Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research.
Combining prostate cancer drugs could delay drug resistance, study finds
Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by the ICR has shown.
Scientists find DNA variants linked with childhood kidney cancer
An international collaboration led by The Institute of Cancer Research (ICR) has found variations of the genetic code in two regions of the genome that increase the risk of developing Wilms tumour.
Existing drugs could treat smokers’ lung cancer
A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC).
Protein ‘block’ kills childhood cancer cells
An experimental drug that blocks an essential cell protein could be used to treat Wilms tumour, a childhood cancer that affects the kidneys.
Men with “breast cancer gene” four times more likely to get prostate cancer
Men with a faulty gene known to increase the risk of breast cancer in women are four times more likely to develop prostate cancer, important new research published in the British Journal of Cancer today shows.
Adding chemotherapy to radiotherapy halves risk of bladder cancer returning
Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy alone.
$10 million boost for efforts to personalise prostate cancer treatment
Professor Johann de Bono from The Royal Marsden and The Institute of Cancer Research (ICR) will collaborate with other leading prostate cancer researchers in a $10 million global effort to drive the development of personalised treatment for this disease.
Gene linked to oestrogen levels and breast cancer risk in younger women
Scientists have found the first direct link between breast cancer risk and genetically-determined levels of the hormone oestrogen in younger women, according to a paper published online this week in the Journal of the National Cancer Institute.
BBC documentary Horizon takes on cancer
BBC’s award winning documentary series, Horizon, will follow the work of The Royal Marsden and The Institute of Cancer Research (ICR) on Tuesday April 10 in their hour-long episode “Horizon: Defeating Cancer”.
Trials show promise of human virus to treat head and neck cancer patients
A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published today in Clinical Cancer Research
Scientists honoured at the AACR conference
Scientists from The Institute of Cancer Research have received several major honours at the American Association for Cancer Research annual meeting this week.
